Send to

Choose Destination
Curr Drug Deliv. 2005 Oct;2(4):401-6.

Lipid-protamine-DNA-mediated antigen delivery.

Author information

Center for Pharmacogenetics, School of Pharmacy, University of Pittsburgh, Pittsburgh, USA.


The development of novel 'new generation' vaccine systems that is based on proteins, peptides or DNA is of great current interest. However, due to the lower efficiencies of these new generation vaccines, they are seldomly used alone. Rather, their formulations often contain adjuvants, either to enhance the immune responses or to reduce dosing. The present chapter will provide a brief overview of the recent advances in peptide-based cancer vaccine adjuvants, focusing mainly on Liposome-Protamine-DNA (LPD) nanoparticle-mediated antigen delivery.

[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Bentham Science Publishers Ltd.
Loading ...
Support Center